Archived Events

2012

March 19-21
BIO Europe Spring 2012

March 11-14
Annual Roth OC Growth Stock Conference

March 8-9
CALBIO 2012

February 23
KOTRA Biotech Partnering Forum

February 15-16
CED Biotech/Life Science 2012

February 13-14
BIO CEO

January 9-11
JP Morgan Investor Conference

January 9-11
BioTech Showcase

2011

October 25-26
10th Annual BIO Investor Forum

October 19
Cato Research and Cato BioVentures Host Wine Tasting and Reception

October 12
NCBIO Annual Meeting

September 28-29
3rd Annual Outsourcing in Clinical Trials New England

September 15
BIOCOM Risk Sharing in Drug Development

September 7
Cato BioVentures and Cato Research Host Wine Tasting and Reception in Boston, Massachusetts

September 7-9
BioPharm America 2011

June 27-30
BIO International Convention

June 8-9
Global Bio and Medical Forum 2011

June 3-7
ASCO 2011 Annual Meeting

May 31 - June 1
BioFinance 2011

May 19, 2011
Crossroad for BioTransfer 2011

May 2-4
Biomarker World Congress 2011

April 20-21
BayBio Annual Conference

April 2-4
Cato BioVentures Attends AACR 102nd Annual Meeting

March 30-31
Summit on Biosimilars and Follow-On Biologics

March 14-16
BIO-Europe Spring 2011

March 9-13
NCCN Annual Conference: Clinical Practice Guidelines and Quality Cancer Care

February 27-March 1
9th Annual BioPartnering North America

February 22-24
BIOCOM Global Life Science Partnering Conference

February 21-22
CHI Early Oncology Partnering Forum

February 21-22
CED Annual Biotech Life Science Conference

January 19
Cato BioVentures Sponsors and Attends the NCBIO Emerging Companies Forum

January 10-13
Cato Research and Cato BioVentures Attend the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA

January 10-12
Cato BioVentures Attends Biotech Showcase 2011

2010

November 3 - 4
Cato BioVentures Participates in 12th Annual Southeast BIO Investor Forum 2010

October 8 - 12
Cato BioVentures Presents at 35th ESMO Congress – A prospective, randomized, double-blind, placebo controlled, group sequential trial of PAS for the treatment of advanced pancreatic cancer.

October 6 - 7
Cato BioVentures Participates in BioContact Québec 2010

October 5 - 6
Cato BioVentures Participates in 9th Annual BIO Investor Forum

September 20 - 22
Cato BioVentures Attends UBS Global Life Sciences Conference in New York

June 30 - July 3
Cato BioVentures Presents at ESMO Conference: 12th Annual World Congress on Gastrointestinal Cancer

June 29 - 30
Cato BioVentures Presents at Cancer Vaccines Conference: A prospective, randomized, double-blind, placebo controlled, group sequential trial of PAS for the treatment of advanced pancreatic cancer

June 15
Cato Research Presents at the 46th DIA Annual Meeting: Challenges in Bringing Novel Cell-based Therapies from Experimental Studies into Successful Clinical Programs

June 14-16
Cato Research Exhibits at ILSI-BioMed 2010 Conference

June 4 - 8
Cato BioVentures Participates in ASCO Annual Meeting

May 3 - 5
Cato BioVentures Attends BIO International Convention

April 20 - 22
Cato BioVentures Participates in CED Venture Conference

April 7
Cato Research Sponsors BayBio 2010 Conference

April 6 - 8
Cato BioVentures Attends bioFinance 2010 Conference in Toronto

March 8 - 10
Cato Research and Cato BioVentures Present at 22nd Annual EuroMeeting in Monaco

February 22 - 23
Cato BioVentures Participates in CED BioTech 2010 Conference

February 8 - 9
Cato BioVentures Participates in 12th Annual Bio CEO & Investor Conference

January 22 - 24
Cato BioVentures Participates in GastroIntestinal Cancers Symposium

January 11 - 14
Cato BioVentures Participates in JP Morgan Investor Conference